מאמרים עם הרשאות לגישה ציבורית - Michael Schotsaertלמידע נוסף
לא זמינים באתר כלשהו: 3
Influenza vaccines: T-cell responses deserve more attention
M Schotsaert, X Saelens, G Leroux-Roels
Expert review of vaccines 11 (8), 949-962, 2012
הרשאות: Research Foundation (Flanders)
Progress in vaccine development for infectious diseases—a Keystone Symposia report
J Cable, BS Graham, RA Koup, RA Seder, K Karikó, N Pardi, DH Barouch, ...
Annals of the New York Academy of Sciences 1524 (1), 65-86, 2023
הרשאות: US National Institutes of Health, Federal Ministry of Education and Research …
Plitidepsin as an Immunomodulator against Respiratory Viral Infections
A Losada, N Izquierdo-Useros, P Aviles, J Vergara-Alert, I Latino, ...
The Journal of Immunology 212 (8), 1307-1318, 2024
הרשאות: European Commission
זמינים באתר כלשהו: 97
Animal models for COVID-19
C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ...
Nature 586 (7830), 509-515, 2020
הרשאות: US National Institutes of Health
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ...
Nature 586 (7827), 113-119, 2020
הרשאות: Bill & Melinda Gates Foundation, US Department of Defense, US National …
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ...
Nature 603 (7902), 687-692, 2022
הרשאות: US Department of Defense, US National Institutes of Health
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ...
Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020
הרשאות: US Department of Defense, US National Institutes of Health, Canadian …
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, H Alshammary, ...
The Lancet Microbe 2 (7), e283-e284, 2021
הרשאות: US National Institutes of Health
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ...
Science 371 (6532), 926-931, 2021
הרשאות: Swiss National Science Foundation, US Department of Defense, US National …
M2e-based universal influenza A vaccine
W Fiers, M De Filette, K El Bakkouri, B Schepens, K Roose, M Schotsaert, ...
Vaccine 27 (45), 6280-6283, 2009
הרשאות: US National Institutes of Health, Research Foundation (Flanders)
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
M Schotsaert, M De Filette, W Fiers, X Saelens
Expert review of vaccines 8 (4), 499-508, 2009
הרשאות: US National Institutes of Health, Research Foundation (Flanders)
Virus-induced senescence is a driver and therapeutic target in COVID-19
S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ...
Nature 599 (7884), 283-289, 2021
הרשאות: US Department of Defense, US National Institutes of Health, German Research …
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience
C Bryce, Z Grimes, E Pujadas, S Ahuja, MB Beasley, R Albrecht, ...
Modern Pathology 34 (8), 1456-1467, 2021
הרשאות: US National Institutes of Health
A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface
S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ...
Cell 177 (5), 1136-1152. e18, 2019
הרשאות: US Department of Energy, US National Institutes of Health
Spatial-temporal lineage restrictions of embryonic p63+ progenitors establish distinct stem cell pools in adult airways
Y Yang, P Riccio, M Schotsaert, M Mori, J Lu, DK Lee, A García-Sastre, ...
Developmental cell 44 (6), 752-761. e4, 2018
הרשאות: US National Institutes of Health
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
R Rathnasinghe, S Strohmeier, F Amanat, VL Gillespie, F Krammer, ...
Emerging microbes & infections 9 (1), 2433-2445, 2020
הרשאות: US Department of Defense, US National Institutes of Health
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
TA Tummino, VV Rezelj, B Fischer, A Fischer, MJ O’meara, B Monel, ...
Science 373 (6554), 541-547, 2021
הרשאות: US Department of Defense, US National Institutes of Health, Howard Hughes …
Defining the risk of SARS-CoV-2 variants on immune protection
MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ...
Nature 605 (7911), 640-652, 2022
הרשאות: US Department of Energy, Bill & Melinda Gates Foundation, US Department of …
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera
S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, F Krammer, V Simon, ...
MedRxiv, 2021
הרשאות: US National Institutes of Health
The SARS-CoV-2 B. 1.1. 529 Omicron virus causes attenuated infection and disease in mice and hamsters
M Diamond, P Halfmann, T Maemura, K Iwatsuki-Horimoto, S Iida, M Kiso, ...
Research square, rs. 3. rs-1211792, 2021
הרשאות: US National Institutes of Health
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב